E. Kobayashi, Y. Ueda, S. Matsuzaki, T. Yokoyama, T. Kimura, K. Yoshino, M. Fujita, T. Kimura, T. Enomoto: Biomarkers for screening, diagnosis, and monitoring of ovarian cancer. In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Band 21, Nummer 11, November 2012, S. 1902–1912, doi:10.1158/1055-9965.EPI-12-0646, PMID 22962405.
R. N. Pillai, J. C. Konje, D. G. Tincello, N. Potdar: Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. In: Human reproduction update. Band 22, Nummer 2, März 2016, S. 228–239, doi:10.1093/humupd/dmv054, PMID 26663220.
C. Rooth: Ovarian cancer: risk factors, treatment and management. In: British journal of nursing. Band 22, Nummer 17, 2013 Sep 12-25, S. S23–S30, doi:10.12968/bjon.2013.22.Sup17.S23, PMID 24067270.
M. Stukan, M. Dudziak, K. Ratajczak, J. P. Grabowski: Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses. In: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. Band 34, Nummer 2, Februar 2015, S. 207–217, doi:10.7863/ultra.34.2.207, PMID 25614393.
R. Longuespée, C. Boyon, A. Desmons, D. Vinatier, E. Leblanc, I. Farré, M. Wisztorski, K. Ly, F. D’Anjou, R. Day, I. Fournier, M. Salzet: Ovarian cancer molecular pathology. In: Cancer metastasis reviews. Band 31, Nummer 3–4, Dezember 2012, S. 713–732, doi:10.1007/s10555-012-9383-7, PMID 22729278.
nih.gov
ncbi.nlm.nih.gov
E. Kobayashi, Y. Ueda, S. Matsuzaki, T. Yokoyama, T. Kimura, K. Yoshino, M. Fujita, T. Kimura, T. Enomoto: Biomarkers for screening, diagnosis, and monitoring of ovarian cancer. In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Band 21, Nummer 11, November 2012, S. 1902–1912, doi:10.1158/1055-9965.EPI-12-0646, PMID 22962405.
R. N. Pillai, J. C. Konje, D. G. Tincello, N. Potdar: Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. In: Human reproduction update. Band 22, Nummer 2, März 2016, S. 228–239, doi:10.1093/humupd/dmv054, PMID 26663220.
C. Rooth: Ovarian cancer: risk factors, treatment and management. In: British journal of nursing. Band 22, Nummer 17, 2013 Sep 12-25, S. S23–S30, doi:10.12968/bjon.2013.22.Sup17.S23, PMID 24067270.
M. Stukan, M. Dudziak, K. Ratajczak, J. P. Grabowski: Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses. In: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. Band 34, Nummer 2, Februar 2015, S. 207–217, doi:10.7863/ultra.34.2.207, PMID 25614393.
A. R. Simmons, K. Baggerly, R. C. Bast: The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas. In: Oncology. Band 27, Nummer 6, Juni 2013, S. 548–556, PMID 23909069, PMC 4085777 (freier Volltext).
R. Longuespée, C. Boyon, A. Desmons, D. Vinatier, E. Leblanc, I. Farré, M. Wisztorski, K. Ly, F. D’Anjou, R. Day, I. Fournier, M. Salzet: Ovarian cancer molecular pathology. In: Cancer metastasis reviews. Band 31, Nummer 3–4, Dezember 2012, S. 713–732, doi:10.1007/s10555-012-9383-7, PMID 22729278.
